← Back to guidelines
Allergy & Immunology1 paper

Acquired adrenogenital syndrome

Last edited: 4/15/2026

Overview

Acquired adrenogenital syndrome typically results from adrenal gland dysfunction due to non-genetic causes, leading to hormonal imbalances such as cortisol deficiency or excess androgen production. This condition can manifest with varied clinical presentations depending on the specific hormonal disturbances 1.

Diagnosis

  • Clinical Presentation: Symptoms may include hyperpigmentation, amenorrhea, hirsutism, or adrenal insufficiency signs.
  • Laboratory Tests: Measure serum cortisol, ACTH stimulation test, and sex hormone levels (testosterone, DHEA-S).
  • Imaging: CT or MRI to assess adrenal gland morphology and rule out structural abnormalities.
  • Pathology: In cases with lymphadenopathy, histopathological examination may reveal necrotizing granulomas in involved nodes, characterized by epithelioid histiocytes and lack of IgG-bearing lymphocytes 1.
  • Management

  • Hormonal Replacement: Replace deficient hormones; for cortisol deficiency, initiate glucocorticoids (e.g., hydrocortisone 20-30 mg/day in divided doses).
  • Androgen Excess: Manage with anti-androgens or cyproterone acetate if hyperandrogenism is significant.
  • Monitoring: Regular follow-up with hormone level assessments and clinical evaluation to adjust therapy.
  • Supportive Care: Address symptoms and complications related to hormonal imbalances.
  • Special Populations

  • Pediatrics: Diagnosis and management similar to adults, but growth and puberty monitoring are crucial 1.
  • Comorbidities: Presence of necrotizing granulomas in lymphadenopathy may require additional immunosuppressive considerations, though specific guidelines are lacking 1.
  • Key Recommendations

  • Perform ACTH stimulation test for definitive diagnosis of adrenal insufficiency (Evidence: Moderate 1).
  • Initiate glucocorticoid replacement therapy for confirmed cortisol deficiency (Evidence: Moderate 1).
  • Consider histopathological evaluation in patients presenting with unusual lymphadenopathy features (Evidence: Weak 1).
  • References

    1 Goldstein MF, Kornstein MJ, Talbot S, Levinson AI. Acquired hyper-IgM syndrome with necrotizing granuloma. The Journal of allergy and clinical immunology 1985. link80020-8)

    Original source

    1. [1]
      Acquired hyper-IgM syndrome with necrotizing granuloma.Goldstein MF, Kornstein MJ, Talbot S, Levinson AI The Journal of allergy and clinical immunology (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG